Recurrence and prognostic model for identifying patients at risk for esophageal cancer after surgery

References

• Domper ArnalMJFerrándezArenas ÁLanasArbeloa ÁEsophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countriesWorld J Gastroenterol201521267933794326185366
   PubMed Web of Science ®Google Scholar
• SchreiberDRineerJVongtamaDImpact of postoperative radiation after esophagectomy for esophageal cancerJ Thorac Oncol20105224425020009774
   PubMed Web of Science ®Google Scholar
• OmlooJMLagardeSMHulscherJBExtended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trialAnn Surg20072466992100018043101
   PubMed Web of Science ®Google Scholar
• MarietteCBalonJMPiessenGFabreSvan SeuningenITribouletJPPattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent diseaseCancer20039771616162312655517
   PubMed Web of Science ®Google Scholar
• Rüdiger SiewertJFeithMWernerMSteinHJAdenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patientsAnn Surg200023239
   Web of Science ®Google Scholar
• TanZMaGYangHZhangLRongTLinPCan lymph node ratio replace pN categories in the tumor-node-metastasis classification system for esophageal cancer?J Thorac Oncol2014981214122125157776
   PubMed Web of Science ®Google Scholar
• AltorkiNKZhouXKStilesBTotal number of resected lymph nodes predicts survival in esophageal cancerAnn Surg2008248222122618650631
   PubMed Web of Science ®Google Scholar
• HsuPKHuangCSWangBYWuYCChouTYHsuWHThe prognostic value of the number of negative lymph nodes in esophageal cancer patients after transthoracic resectionAnn Thorac Surg2013963995100123866797
   PubMed Web of Science ®Google Scholar
• WuSGLiFYZhouJPrognostic value of different lymph node staging methods in esophageal squamous cell carcinoma after esophagectomyAnn Thorac Surg201599128429025440270
   PubMed Web of Science ®Google Scholar
• TwineCPLewisWGMorganMAThe assessment of prognosis of surgically resected oesophageal cancer is dependent on the number of lymph nodes examined pathologicallyHistopathology2009551465219614766
   PubMed Web of Science ®Google Scholar
• LuJTaoHSongDChenCRecurrence risk model for esophageal cancer after radical surgeryChin J Cancer Res201325554955524255579
   PubMed Web of Science ®Google Scholar
• PeyreCGHagenJADemeesterSRPredicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodesAnn Surg2008248697998519092342
   PubMed Web of Science ®Google Scholar
• RiceTWIshwaranHHofstetterWLRecommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manualsDis Esophagus201629889790527905172
   PubMed Web of Science ®Google Scholar
• SmithDDSchwarzRRSchwarzREImpact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population databaseJ Clin Oncol200523287114712416192595
   PubMed Web of Science ®Google Scholar
• LiBXiangJZhangYComparison of Ivor-Lewis vs sweet esophagectomy for esophageal squamous cell carcinoma: a randomized clinical trialJAMA Surg2015150429229825650816
   PubMed Web of Science ®Google Scholar
• RiceTWIshwaranHKelsenDPRecommendations for neo-adjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manualsDis Esophagus201629890691227905170
   PubMed Web of Science ®Google Scholar
• AghaRABorrelliMRVella-BaldacchinoMThavayoganROrgillDPSTROCSS GroupThe STROCSS statement: strengthening the reporting of cohort studies in surgeryInt J Surg20174619820228890409
   PubMed Web of Science ®Google Scholar
• RiceTWIshwaranHFergusonMKBlackstoneEHGoldstrawPCancer of the esophagus and esophagogastric junction: an eighth edition staging primerJ Thorac Oncol2017121364227810391
   PubMed Web of Science ®Google Scholar
• BollschweilerEBaldusSESchröderWSchneiderPMHölscherAHStaging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?J Surg Oncol200694535536316967455
   PubMed Web of Science ®Google Scholar
• GreensteinAJLitleVRSwansonSJDivinoCMPackerSWisniveskyJPEffect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancerCancer200811261239124618224663
   PubMed Web of Science ®Google Scholar
• PeyreCGHagenJADemeesterSRThe number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resectionAnn Surg20082484190197
   Web of Science ®Google Scholar
• LiHZhangYCaiHXiangJPattern of lymph node metastases in patients with squamous cell carcinoma of the thoracic esophagus who underwent three-field lymphadenectomyEur Surg Res20073911617106199
   PubMed Web of Science ®Google Scholar
• ChenJLiuSPanJThe pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinomaEur J Cardiothorac Surg200936348048619502077
   PubMed Web of Science ®Google Scholar
• ChenGWangZLiuXYLiuFYRecurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomyWorld J Surg200731511081115
   Web of Science ®Google Scholar
• LuJCKongCTaoHRadiotherapy with or without concurrent chemotherapy for lymph node recurrence after radical surgery of thoracic esophageal squamous cell carcinomaInt J Radiat Oncol Biol Phys201078371071420172661
   PubMed Web of Science ®Google Scholar
• ZhuZChenHYuWNumber of negative lymph nodes is associated with survival in thoracic esophageal squamous cell carcinoma patients undergoing three-field lymphadenectomyAnn Surg Oncol20142192857286324740827
   PubMed Web of Science ®Google Scholar
• BogoevskiDOnkenFKoenigAIs it time for a new TNM classification in esophageal carcinoma?Ann Surg2008247463364118362626
   PubMed Web of Science ®Google Scholar
• RiceTWRuschVWIshwaranHBlackstoneEHWorldwide Esophageal Cancer CollaborationCancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging ManualsCancer2010116163763377320564099
   PubMed Web of Science ®Google Scholar
• AjaniJACorreaAMHofstetterWLClinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancerAnn Oncol201223102638264222831985
   PubMed Web of Science ®Google Scholar
• BurmeisterBHSmithersBMGebskiVSurgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trialLancet Oncol20056965966816129366
   PubMed Web of Science ®Google Scholar
• TepperJKrasnaMJNiedzwieckiDPhase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781J Clin Oncol20082671086109218309943
   PubMed Web of Science ®Google Scholar
• SteinHJvon RahdenBHSiewertJRSurvival after oesophagectomy for cancer of the oesophagusLangenbecks Arch Surg2005390428028515252736
   PubMed Web of Science ®Google Scholar
• SunZZhuGLLuCThe impact of N-ratio in minimizing stage migration phenomenon in gastric cancer patients with insufficient number or level of lymph node retrieved: results from a Chinese mono-institutional study in 2159 patientsAnn Oncol200920589790519179553
   PubMed Web of Science ®Google Scholar
• PrenzelKLKönigASchneiderPMReduced incidence of nodal micrometastasis after major response to neoadjuvant chemo-radiation in locally advanced esophageal cancerAnn Surg Oncol200714295495917103071
   PubMed Web of Science ®Google Scholar
• YangHLiuHChenYNeoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): a Phase III multicenter, randomized, open-label clinical trialJ Clin Oncol201836272796280330089078
   PubMed Web of Science ®Google Scholar